FARALLON CAPITAL MANAGEMENT LLC

Q3 2022 13F-HR Holdings

Location
San Francisco, CA
Holdings as of
9/30/2022
Date filed
11/14/2022
Form type
13F-HR
Num holdings
298
Total value ($000)
$16,822,364
Net value change ($000)
+570,918 (3.5%)
New positions
16
Sold out positions
17
Turnover %
14.9%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 8/15/2022 Next filing: 2/14/2023 SEC filing

Snapshot: Change Analysis

Compared to Q2 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Change Healthcare Inc. 496,917 NEW
TWTR 339,979 NEW
Biohaven Pharmaceutical Holding Co Ltd. 294,452 NEW
HUM 121,880 NEW
Horizon Therapeutics Public Ltd Co 110,178 NEW
SPGI 108,196 97.6%
NIELSEN HLDGS PLC 68,495 NEW
MASI 55,968 219.6%
ChemoCentryx, Inc. 41,328 NEW
CLVT 40,359 11.9%
Top Reduces (Value $000, Stocks/ETFs)
COHERENT INC -153,870 -100.0%
HWM -130,761 -30.0%
TRU -126,524 -21.2%
IQV -116,294 -16.7%
TMO -105,906 -15.7%
CSGP -93,649 -31.2%
AVTR -92,074 -56.1%
TSM -92,061 -100.0%
LU -90,280 -63.4%
BSX -90,193 -16.1%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 1,859,719 (11.1% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type